DAWN PATRICK: Open Payments
NPI 1609234871 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 7 payments from 5 companies in 2025. Trend: 2023 $713 · 2024 $1,140 · 2025 $548
Food & beverage: $437Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $228 |
| E.R. Squibb & Sons, L.L.C. | 1 | $129 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Alkermes, Inc. | 2 | $50 |
| Indivior Inc. | 1 | $19 |
Products named: COBENFY, REXULTI, UZEDY, VIVITROL, ARISTADA, SUBLOCADE.
Industry payments across MO — which companies pay providers there.
